Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/23/2026

Distinguishing Respiratory Conditions

Introduction to Respiratory Condition Diagnosis

  • The European Respiratory Society suggests that identifying focal chest signs, fever patterns, wheezing characteristics, and smoking history is key to differentiating respiratory conditions, with chest radiography reserved for suspected pneumonia based on specific clinical triggers 1, 2

Step 1: Rule Out Pneumonia First

  • The European Respiratory Society recommends suspecting pneumonia when any of the following are present: new focal chest signs on auscultation, dyspnea or tachypnea, pulse rate >100 bpm, fever persisting >4 days, or dull percussion note or pleural rub 1, 2, 3
  • The European Respiratory Society suggests using C-Reactive Protein (CRP) to refine suspicion of pneumonia: CRP <20 mg/L indicates pneumonia is highly unlikely, while CRP >100 mg/L indicates pneumonia is likely 2
  • The European Respiratory Society states that chest X-ray is the gold standard and should be performed when clinical suspicion persists after CRP testing 1, 2

Step 2: Differentiate Viral URTI from Lower Respiratory Tract Infections

  • The European Respiratory Society characterizes viral URTI as having predominantly upper respiratory symptoms, absence of dyspnea, and normal respiratory rate 2, 3
  • The European Respiratory Society characterizes acute bronchitis as having cough as the predominant symptom, absence of focal chest signs, no dyspnea or tachypnea, and fever typically <4 days 1, 2, 3

Step 3: Identify Asthma/COPD Exacerbation

  • The European Respiratory Society suggests considering lung function testing when ≥2 of the following are present: wheezing, prolonged expiration, smoking history, history of allergy, or previous consultations for wheezing or cough 1, 2, 3
  • The American Journal of Respiratory and Critical Care Medicine states that key clinical features supporting true exacerbation include increased dyspnea, increased sputum volume and purulence, and increased cough and wheeze 4

Step 4: Assess Complication Risk

  • The Clinical Microbiology and Infection journal suggests that high-risk features requiring close monitoring in patients >65 years include presence of COPD, diabetes, or heart failure, previous hospitalization, oral glucocorticoid use, recent antibiotic use, general malaise, absence of upper respiratory symptoms, confusion or diminished consciousness, and vital sign abnormalities 2
  • The Clinical Microbiology and Infection journal states that for patients <65 years, diabetes and pneumonia diagnosis are primary risk factors, and active malignancy, liver disease, renal disease, and immunocompromising conditions increase risk at all ages 2

Differentiating Acute COPD Exacerbation from Asthma Attack

1. Clinical Assessment Framework

2. Spirometry‑Based Diagnostic Criteria

2.1 Confirmation of COPD

2.2 Indication of Asthma

3. Interpretation of Bronchodilator Response Patterns

3.1 Volume Responders (Hidden COPD)

3.2 Flow Responders (Potential Future Obstruction)

4. Testing Recommendations

5. Limitations of Bronchodilator Responsiveness